drugset / Trial / NCT06523803
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to find out if ZW171 is safe and can treat participants with advanced (locally advanced \[inoperable\] and/or metastatic) mesothelin-expressing cancers.
Timeline
- Start
- 2024-09-30
- Primary completion
- 2025-09-30
- Completion
- 2025-10-01
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZW171 | Unknown | — | — |
Indications
No indication recorded.